Psoriasis Clinical Trial
Predicting Medication Response for Autoimmune Disease
Summary
Coral is conducting a large study comparing and predicting the relative effectiveness of different medications for autoimmune patients.
Patients with Inflammatory Bowel Disease (IBD) who have been diagnosed with either Ulcerative Colitis or Crohn's Disease and are undergoing treatment are eligible to participate.
Patients with Rheumatoid Arthritis (RA) and Psoriasis (Ps) will also be enrolled.
A novel clinical test will be performed to predict the responsiveness of a particular patient to different immune modulating therapies used in these conditions.
Eligibility Criteria
Inclusion Criteria:
Ulcerative Colitis, Crohn's Disease, Rheumatoid Arthritis, Psoriasis diagnosis
On or about to begin a treatment for condition above
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
San Francisco California, 94107, United States
How clear is this clinincal trial information?